Knight Therapeutics Inc.

10:08 AM EST - Knight Therapeutics Inc. : Reported financial results for its first quarter ended March 31, 2021. All currency amounts are in thousands except for share and per share amounts. Revenues were $46,069, an increase of $230 or 1% over prior year. Gross margin generated of $20,580 or 45% compared to $19,860 or 43% in prior year. Adjusted EBITDA 1 was $5,580, an increase of $2,383 or 75% over prior year.Interest income generated of $1,998 a decrease of $2,651 or 57% over prior year. Net income was $3,558 compared to net loss of $9,477 in prior year. Knight Therapeutics Inc. shares T.GUD are trading up $0.10 at $5.35.

Stocks in Play